Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.

Background: Weekly maternal intravenous immunoglobulin (IVIG) is the cornerstone of antenatal treatment of foetal and neonatal alloimmune thrombocytopenia (FNAIT). The aim of this study was to describe the neonatal outcome and management in neonates with FNAIT treated antenatally with IVIG.

Materials And Methods: All neonates treated antenatally and delivered at our centre between 2006 and 2012 were included in the study.